
PainReform Ltd. PRFX
€ 1.62
-1.81%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
PainReform Ltd. Abschreibung & Amortisation 2011-2026 | PRFX
Abschreibung & Amortisation Jährlich PainReform Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 7 K | - | 1 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7 K | 1 K | 4 K |
Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler
| Name | Abschreibung & Amortisation | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
Exelixis
EXEL
|
29.1 M | $ 48.43 | 9.03 % | $ 13.2 B | ||
|
Fortress Biotech
FBIO
|
403 K | $ 2.56 | 3.96 % | $ 71.4 M | ||
|
Genprex
GNPX
|
6.69 K | $ 0.9 | 2.02 % | $ 839 K | ||
|
Athira Pharma
ATHA
|
972 K | - | - | $ 269 M | ||
|
Ionis Pharmaceuticals
IONS
|
10 M | $ 76.96 | 2.27 % | $ 12.3 B | ||
|
Kymera Therapeutics
KYMR
|
8.31 M | $ 86.14 | 4.15 % | $ 7.28 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
66 K | - | - | $ 231 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
35.2 M | $ 229.83 | -1.06 % | $ 4.2 B | ||
|
INmune Bio
INMB
|
84 K | $ 1.52 | -1.3 % | $ 37.6 M | ||
|
Liquidia Corporation
LQDA
|
1.53 M | $ 41.84 | 4.26 % | $ 3.6 B | ||
|
Mirum Pharmaceuticals
MIRM
|
24.2 M | $ 107.42 | 1.52 % | $ 5.39 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
920 K | $ 22.32 | -0.13 % | $ 3.7 B | ||
|
MannKind Corporation
MNKD
|
12.3 M | $ 3.68 | 28.5 % | $ 1.12 B | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
105 K | $ 3.13 | 0.55 % | $ 651 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
24 K | $ 3.47 | -8.44 % | $ 5.71 M | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
22 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
13 K | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
700 K | $ 23.86 | 1.88 % | $ 3.04 B | ||
|
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | ||
|
Puma Biotechnology
PBYI
|
10.9 M | $ 7.5 | 2.04 % | $ 375 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B |